Risperdal Recall

Although a Risperdal recall has not been announced due to side effects associated with the drug, lawsuits alleging that the antipsychotic medication caused gynecomastia (male breasts) and other injuries continue to rise. The manner in which Risperdal has been marketed has also caught the attention of the U.S. Department of Justice, resulting in the announcement of a massive settlement in November 2013.

Even though there has not been an official recall, young men and boys who suffered from gynecomastia related to the drug can still file a lawsuit seeking compensation for emotional distress and other damages. Bernstein Liebhard LLP is offering free legal evaluations to victims of Risperdal male breast growth. To find out if you might qualify for compensation, please contact our office today by calling 1 (855) 511-1001.

Risperdal Side Effects

Marketed by Janssen Pharmaceuticals, a division of Johnson & Johnson, Risperdal is an atypical antipsychotic designed to target the brain’s serotonin and dopamine receptors and is prescribed for the treatment of schizophrenia and bipolar disorder in adults and adolescents. Risperdal is also approved for the treatment of irritability in children 5-16 years of age who are diagnosed with autistic disorder and is often used off-label to treat attention deficit hyperactivity disorder (ADHD).

Risperdal lawsuit claims have been filed nationwide over allegations that Johnson & Johnson and Janssen were aware that taking Risperdal could lead to gynecomastia, yet hid that information from the public. The majority of those cases, along with Risperdal lawsuits that allege other injuries, are pending in a consolidated litigation underway in Pennsylvania’s Court of Common Pleas. A handful of cases have settled.

In November 2013, Johnson & Johnson agreed to pay more than $2.2 billion to settle federal charges that it improperly marketed Risperdal and other drugs. The settlement included criminal fines and forfeiture of $485 million and $1.72 billion in civil penalties, and also resolved similar allegations that were brought by 45 states, according to a The New York Times report. Among other things, the government had alleged that Johnson & Johnson and its Janssen Pharmaceuticals unit had improperly marketed Risperdal for use in children and elderly dementia patients. While the companies pled guilty to a criminal misdemeanor charge involving the marketing of Risperdal for use in the elderly, they did not admit to marketing the drug for children prior to its 2006 approval for pediatric uses.

Risperdal Recall Announced

In June 2013, Johnson & Johnson announced a recall for a single lot of Risperdal Consta. This long-lasting, injectable form of the drug is used to treat bipolar disorder and schizophrenia. The action was taken after mold was detected during a routine testing process. The recall did not impact the general public, as the affected lot was only distributed to wholesalers, distributors, pharmacies, and healthcare providers. The action also had nothing to do with any of the side effects alleged in Risperdal lawsuits.

Filing a Lawsuit in the Absence of a Recall

While a Risperdal recall has not been announced in connection with gynecomastia or any other Risperdal side effects, anyone harmed by this medication still has a legal right to pursue compensation from Johnson & Johnson and Janssen. If you would like to learn more about filing a Risperdal lawsuit, please contact Bernstein Liebhard LLP today by calling 1 (855) 511-1001 for a free case review.

Do I Have a Case?

  • For a free and confidential Risperdal case evaluation, please complete this form and we will contact you shortly.
  • This field is for validation purposes and should be left unchanged.